Accuray Incorporated Stock News

The Zacks Medical - Instruments industry is growing on COVID-support business gains. TMO, STE and ARAY are set to gain the most. Yet, demand for base business is on the decline with the new COVID vari

The Zacks Medical - Instruments industry is growing on COVID-support business gains. TMO, STE and ARAY are set to gain the most.

Metropolitan Life Insurance Co NY lifted its position in Accuray Incorporated (NASDAQ:ARAY) by 62,992.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,666 shares of the medical equipment providers stock after buying an additional 17,638 shares during the period. Metropolitan []

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Investors continue to be optimistic about Accuray (ARAY) owing to its slew of software upgrades.

Investors continue to be optimistic about Accuray (ARAY) owing to its slew of software upgrades.

Price T Rowe Associates Inc. MD cut its holdings in shares of Accuray Incorporated (NASDAQ:ARAY) by 14.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 96,665 shares of the medical equipment providers stock after selling 16,830 shares during the []

Accuray's better than expected fiscal first quarter results underline ongoing progress in the story. Focused R&D efforts have significantly upgraded the capabilities and appeal of Accuray's systems, p

Accuray Incorporated (NASDAQ:ARAY) shares, rose in value on Friday, 11/26/21, with the stock price down by -3.21% to the previous days close as strong demand from buyers drove the stock to $5.12. Actively observing the price movement in the last trading, the stock closed the session at $5.29, falling within a range of $4.925 and Accuray Incorporated (NASDAQ: ARAY) Is An Exciting Stock To Watch. Read More »

Squarepoint Ops LLC reduced its holdings in shares of Accuray Incorporated (NASDAQ:ARAY) by 84.4% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 27,032 shares of the medical equipment providers stock after selling 146,778 shares during the period. Squarepoint Ops LLCs holdings []

Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

The trading price of Accuray Incorporated (NASDAQ:ARAY) closed lower on Monday, November 22, closing at $5.32, -2.03% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

In the last trading session, 1.3 million shares of the Accuray Incorporated (NASDAQ:ARAY) were traded, and its beta was 1.88. Most recently the companys share price was $5.43, and it changed around -$0.19 or -3.38% from the last close, which brings the market valuation of the company to $510.58M. ARAY currently trades at a discount Accuray Incorporated (NASDAQ: ARAY) Is Something To Consider Today. Read More »

Northern Trust Corp trimmed its position in shares of Accuray Incorporated (NASDAQ:ARAY) by 5.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 926,951 shares of the medical equipment providers stock after selling 49,802 shares during the period. Northern Trust Corps holdings in []